Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Tropis needle-free intradermal delivery on routine polio immunization
PACTR202308820044137Unknown
- Sponsor
- PharmaJet
- Start
- Jul 2023
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of trivalent inactivated polio vaccine in poliomyelitis, sponsored by PharmaJet. Primary endpoint: Two-dose IPV coverage. Status: unknown.
02
Drugs
trivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on PACTR202308820044137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202308820044137.